Fresco 2 Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fresco 2 Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fresco 2 Study Today - Breaking & Trending Today

FRESCO-2: A Global Phase 3 Multiregional Clinical Trial Evaluating the Efficacy and Safety of Fruquintinib in Patients With Refractory Metastatic Colorectal Cancer

Published: August 30, 2023

Arvind Dasari, MD, MS, presents data from the FRESCO-2 clinical trial evaluating fruquintinib in patients with refractory metastatic colorectal cancer, and provides insights on the clinical implications of the results.

Source: onclive.com

Related Topics:

Arvind DasariGlobal PhaseClinical Trial EvaluatingPatients With Refractory Metastatic ColorectalPartnership WithColorectal CancerRefractory Metastatic Colorectal CancerMetastatic Colorectal CancerFresco 2Fresco 2 TrialFresco 2 StudyClinical TrialOverall Survival